WALNUT CREEK, Calif., April 10 /PRNewswire-FirstCall/ -- Longs Drug
Stores Corporation (NYSE: LDG) today reported preliminary total retail drug
store sales for the five-week and nine-week periods ended April 3, 2008.
Periods ended April 3, 2008
Month Quarter to Date
(Dollars in millions) (5 weeks) (9 weeks)
Total retail drug store sales $474 $853
Increase from comparable prior year
period 4.7% 4.0%
Same-store sales increase:
Pharmacy 0.1% 1.0%
Front-end 5.7% 3.2%
Total 2.8% 2.1%
Longs estimated that preliminary March front-end same-store sales were favorably impacted by approximately 350 to 400 basis points as a result of the three-week shift in Easter holiday sales. Easter occurred on March 23 this year versus April 18 last year.
Longs estimated that preliminary March pharmacy same-store sales were unfavorably impacted by approximately 525 to 575 basis points as a result of recent generic introductions being substituted for higher-priced brand name drugs. In addition, the switch of the prescription allergy medicine Zyrtec to over-the-counter status and a mild conclusion to the cold and flu season versus last year had an unfavorable impact of approximately 125 to 150 basis points on pharmacy same-store sales.
About the Company
Headquartered in Walnut Creek, California, Longs Drug Stores Corporation (NYSE: LDG) is one of the most recognized retail drug store chains on the West Coast and in Hawaii. The Company operates 512 retail pharmacies and offers a wide assortment of merchandise focusing on health, wellness, beauty and convenience. Longs also provides pharmacy benefit management services and Medicare beneficiary prescription drug plans through its wholly-owned subsidiary, RxAmerica, LLC. Additional information about Longs and its services is available at http://www.longs.com and more information about RxAmerica is available at http://www.rxamerica.com.
|SOURCE Longs Drug Stores Corporation|
Copyright©2008 PR Newswire.
All rights reserved